Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation
J. Alejandro Madrigal(Royal Free London NHS Foundation Trust), Dominique Farge(Hôpital Saint-Louis), Jakob Passweg(University Hospital of Basel), Andrew R. Gennery(Newcastle upon Tyne Hospitals NHS Foundation Trust), Christina Peters(Cancer Research Institute of the Slovak Academy of Sciences), Helen Baldomero(University Hospital of Basel), Simone Cesaro(Azienda Ospedaliera Universitaria Integrata Verona), Mohamad Mohty(Sorbonne Université), Francesco Lanza(Ospedale "Santa Maria delle Croci" di Ravenna), J.H. Frederik Falkenburg(Leiden University Medical Center), Andrea Velardi(University Niccolò Cusano), H. Bobby Gaspar(University College London), Jörg Halter(University Hospital of Basel), Rafael F. Duarte(Institut Català d'Oncologia), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Peter Dreger(Heidelberg University), Nicolaus Kröger(Universität Hamburg), Judith Marsh(King's College London)
Cited by 178
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Activation-Induced Cytidine Deaminase (AID) Deficiency Causes the Autosomal Recessive Form of the Hyper-IgM Syndrome (HIGM2)
|Cell|2000|1.6k
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2017|1.2k